ロード中...
The supplementary therapeutic DMARD role of low-dose glucocorticoids in rheumatoid arthritis
The management of rheumatoid arthritis (RA) is primarily based on the use of disease-modifying antirheumatic drugs (DMARDs), mainly comprising synthetic chemical compounds (that is, methotrexate or leflunomide) and biological agents (tumor necrosis factor inhibitors or abatacept). On the other hand,...
保存先:
| 出版年: | Arthritis Res Ther |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4249490/ https://ncbi.nlm.nih.gov/pubmed/25608624 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar4685 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|